Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2020-10-23 Board/Management Inform…
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about a scheduled Board Meeting to consider and approve unaudited financial results for the quarter and six months ended September 30, 2020. It references compliance with SEBI regulations and insider trading rules. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of an upcoming board meeting and financial results approval, not the financial report or earnings release itself. The document length is short (1858 characters), and it serves as a notification to the exchanges. Therefore, it fits the category of Board/Management Information (MANG), as it relates to a board meeting announcement and regulatory compliance regarding insider trading and financial results approval.
2020-10-23 English
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2020 ,inter alia, to consider and approve unaudited results (standalone ....
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about a scheduled Board Meeting to consider and approve unaudited financial results for a quarter and six months period. It references Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings. The document does not contain any financial data or results itself, but is an announcement of an upcoming board meeting where financial results will be approved. The document length is short (1858 characters), and it serves as a notification rather than a report or detailed financial disclosure. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related disclosures.
2020-10-23 English
Compliance Certificate under regulation 40(9) & 40 (10) of the SEBI (LODR) Regulations, 2015 for the half year ended September 30, 2020
Regulatory Filings
2020-10-16 English
Updates
Regulatory Filings
2020-10-12 English
Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020.
Regulatory Filings
2020-10-12 English
Compliance Certificate - Regulation 7(3) for the period ended September 30, 2020 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 100 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. Given the lack of content, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2020-10-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.